肝酶作为COVID-19患者死亡率的预测因素? 一个横截面研究

Mansour Abbasi1, Babak Choobi Anzali2, Hamid Reza Mehryar2

  • 1Department of Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Toxicology reports
|March 4, 2024
PubMed
概括

高水平的肝酶,阿斯巴酸氨基转移酶 (AST) 和氨基转移酶 (ALT),与住院COVID-19患者的更糟糕的结果有关. 监测这些酶可以帮助预测预后并指导护理.